Selective activation of androgen receptor to treat estrogen receptor positive breast cancer. [ 2015 - 2017 ]

Research Grant

Researchers: Prof Wayne Tilley (Principal investigator) ,  A/Pr Jason Carroll ,  Dr Theresa Hickey

Brief description A major challenge in breast cancer research is to find alternative drugs to treat women with drug-resistant disease. What’s new and exciting is a novel type of drug that mimics the ability of natural androgen hormones to inhibit estrogen action in breast cancers without undesirable masculinising side effects. This research will greatly facilitate the introduction of a new breast cancer treatment into clinics worldwide by the development of a new test that can predict response to this treatment.

Funding Amount $AUD 843,325.74

Funding Scheme Project Grants

Notes Standard Project Grant